| Tag | Content |
|---|
EnhancerAtlas ID | HS093-23766 |
Organism | Homo sapiens |
Tissue/cell | HL-60 |
Coordinate | chr4:84161240-84162440 |
SNPs | | Number: 1 | ID | Chromosome | Position | Genome Version |
|
TF binding sites/motifs | | TF | JASPAR ID | Coordinate | Motif Sequence | Strand | -Log10(p-value) |
| LMX1B | MA0703.2 | chr4:84162094-84162105 | GTTTTAATTAA | + | 6.14 | | Lhx3 | MA0135.1 | chr4:84162098-84162111 | TAATTAATTAATT | + | 6.78 | | Lhx3 | MA0135.1 | chr4:84162102-84162115 | TAATTAATTAATT | + | 6.78 | | Lhx3 | MA0135.1 | chr4:84162106-84162119 | TAATTAATTAATT | + | 6.78 | | Lhx3 | MA0135.1 | chr4:84162110-84162123 | TAATTAATTAATT | + | 6.78 | | Lhx3 | MA0135.1 | chr4:84162099-84162112 | AATTAATTAATTA | - | 6.78 | | Lhx3 | MA0135.1 | chr4:84162103-84162116 | AATTAATTAATTA | - | 6.78 | | Lhx3 | MA0135.1 | chr4:84162107-84162120 | AATTAATTAATTA | - | 6.78 | | Lhx3 | MA0135.1 | chr4:84162111-84162124 | AATTAATTAATTT | - | 6.92 | | POU6F1 | MA0628.1 | chr4:84162100-84162110 | ATTAATTAAT | + | 6.02 | | POU6F1 | MA0628.1 | chr4:84162104-84162114 | ATTAATTAAT | + | 6.02 | | POU6F1 | MA0628.1 | chr4:84162108-84162118 | ATTAATTAAT | + | 6.02 | | POU6F1 | MA0628.1 | chr4:84162112-84162122 | ATTAATTAAT | + | 6.02 | | POU6F1 | MA0628.1 | chr4:84162100-84162110 | ATTAATTAAT | - | 6.02 | | POU6F1 | MA0628.1 | chr4:84162104-84162114 | ATTAATTAAT | - | 6.02 | | POU6F1 | MA0628.1 | chr4:84162108-84162118 | ATTAATTAAT | - | 6.02 | | POU6F1 | MA0628.1 | chr4:84162112-84162122 | ATTAATTAAT | - | 6.02 |
|
| | Number of super-enhancer constituents: 4 | ID | Coordinate | Tissue/cell |
| SE_10054 | chr4:84160707-84162870 | CD14 | | SE_43772 | chr4:84160647-84162870 | MM1S | | SE_63025 | chr4:84132108-84203641 | Tonsil | | SE_67400 | chr4:84160647-84162870 | MM1S |
|
| | Diseases: AD,Huntington,Obesity,Parkinson,Prostate cancer,Schizophrenia and Sleep disorder | | Number of disease enhancers: 1 | Chromosome | Start | End |
|
| | Number: 1 | ID | Chromosome | Start | End |
| GH04I083239 | chr4 | 84160884 | 84162567 |
|
Enhancer Sequence | GCACTTCAAA TGCTAAATTC CTATTTCTAG ATTAAAAGTA ACAAACACGC ATATATCACA 60
TTGTCCAGGC CCTTGATGCA TATTGAAAAC ATTCACACCA CACACATACA CTCACATACA 120
CATGCACACA CGCAAACACG TGTGTGCACA TACACACACA TGCACACAGG AAATACAGAA 180
AACTATGCAC CAAAATAGAG ATGATTATTA TCACGTAGGG TCTATTTTGT GCAGGTATCA 240
ACATATAAAT ATTCCCAGAG GAATTTCATA ATTCAGGATT TCGTGAAGAT GACAAAAGAA 300
GAATGACTGC ATCTATTCTG AACTTTACCC AGTTTTGGAG TCCTGATGTC AGTCACTACT 360
TCTTACTTTC TAAGGCACTG ATGGTAACAA TTAACTTCTG TGGCCAAAGG ACTATTTCCA 420
GGATGGCCTG GATCCTCTTT TTGCCATCCC ACACTGCTCT CACACCACAC TGTCTGAGAT 480
GTCTACTTCC TGCATCTGGG CCCTTATTAT AAATGAAAGT AGTTCTTTGC TTTGGTCCTG 540
GCTCAAAATA TAGCCCTCAA CTACTGAGTC TTTAGCAATT CCTTTGCATC TGATTGCAGA 600
TGCAATTGAA AATTGCAACA TAACTGCAAT TGCCTTGCCT GTGAAAAGGC AATATAACTG 660
ACGGTTGAAA GCGAAGATTC TTTCAGTTCC CTCAACTGAA TAATGAGTTC GCAGATGTAA 720
AGTGCTTAGG ACAGCACCTG GCATGTAGTA AGTAGCACTC TGTGGGTACC GGCTGTTATC 780
ATTTCTCTAT TATCTGTTTC TCCTGACAGA CCTGTAGATA GTGGAACTTT GAATCTTCTT 840
CACTTTATTT TATTGTTTTA ATTAATTAAT TAATTAATTA ATTTTTTTTT AAAGACAGAG 900
TCTTACTCTG TTGTCCTGGT TGGAGTATAG TTAAGCAATC ATAGCTCACT GTAACCTCAA 960
ACAACTGAGC TCAAGCAATC TTCCTGCTTC AGCCTCCCAA GTAGCTAGGA CTACAGGCAT 1020
GCATCACCTC ACCCAGCGAA TTTTTAAATT TTTGTAGAAA TGAGGTCTTG CTATGTTGTC 1080
CAGGTTGGTC TTGAAACCCT GACTGCAACG GATCATCCTG CCTTGGCCTC CCAAAGCTCT 1140
GGCATTACAG GTGTGAGCCA CTGTGCCTGG CTTCCACTTT ATTTTAAGAA GGAAACCACA 1200
|
